Related Experiment Videos
Genomewide two-generation screens for recessive mutations by ES cell mutagenesis.
Robert J Munroe1, Susan L Ackerman, John C Schimenti
1The Jackson Laboratory, Bar Harbor, Maine 04609, USA.
Summary
This study presents a faster method for mouse forward genetic screens using mutagenized embryonic stem cells. This approach reduces breeding time to two generations, accelerating mutation discovery and analysis.
Area of Science:
- Genetics
- Genomics
- Developmental Biology
Background:
- Forward genetic screens in mice typically use N-ethyl-N-nitrosourea (ENU) mutagenesis in male germlines.
- This traditional method requires three generations of breeding to achieve homozygous mutations for phenotyping.
- An alternative involves chemical mutagenesis of embryonic stem (ES) cells.
Purpose of the Study:
- To demonstrate the feasibility of performing genome-wide mutation screens in mice using mutagenized ES cells.
- To establish a more efficient strategy for generating homozygous mutations for genetic screens.
- To compare the efficiency of ES cell-based mutagenesis with traditional ENU mutagenesis.
Main Methods:
- Embryonic stem (ES) cells were treated with ethylmethane sulfonate (EMS).
- Chimeras were generated from mutagenized ES cells.
- Mice potentially homozygous for mutations were obtained by crossing chimeras to their daughters or by intercrossing chimera offspring.
- This resulted in a two-generation breeding scheme.
Main Results:
- The ES cell-based strategy successfully generated mice potentially homozygous for mutations in two generations.
- This method leverages the transmission of a single mutagenized diploid genome from chimeras.
- The strategy doubles the number of screenable mutations per pedigree compared to ENU mutagenesis.
Conclusions:
- Mutagenesis of ES cells offers a more efficient two-generation approach for mouse forward genetic screens.
- This method provides advantages in speed, mutation frequency, and flexibility compared to traditional ENU mutagenesis.
- The strategy facilitates the production of quality-controlled, long-term supplies of mutagenized cells for genetic screens.